Melanoma is one of the types of cancer that poses the greatest challenge to researchers because it manifests itself in many ways, it contains a large number of mutations and … Continue Reading Researchers identify a new molecular biomarker for malignant melanoma.
Melanoma incidence has been rapidly increasing worldwide, with fewer than 10% of people whose melanoma tumours have spread or metastasized surviving longer than a decade after detection. Despite the considerable … Continue Reading New ctDNA blood-test for melanoma beats standardised test in human trials.
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. Most often, prostate cancer spreads to the bones and also to the liver … Continue Reading Nanoparticles hitchhike on whiteblood cells to kill tumour cells in bloodstream.
Cancer is recognized globally as one of the most costly and deadly health problems, with lung cancer being the leading cause of cancer related deaths. Lung cancer is classified into … Continue Reading Biomarker for most common form of lung cancer in it’s early stages identified.
Skin cancer is the most common of all cancers, and melanoma, which accounts for 2% of skin cancer cases, is responsible for nearly all skin cancer deaths. Melanoma rates in … Continue Reading Researchers identify the precise trigger of melanoma.
In a new study from Saint Louis University, researchers discovered that drugs targeting the A3 adenosine receptor can turn off pain signals in the spinal cord to provide relief from … Continue Reading Researchers use A3 adenosine receptors to activate ‘off signals’ for chronic pain.
For most cancer patients, primary tumours are often not the most deadly. Instead, it is the metastatic tumours – tumours that spread from their original location to other parts of … Continue Reading New MEMS is the first to capture and classify CTC’s by phenotype.